APA (7th ed.) Citation

J, S., SH, K., KH, H., MH, K., YK, A., IS, S., . . . CJ, K. (2026). Corrigendum to "Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension" (Clin Ther. 2025 Oct 28. [Epub ahead of print]). Clinical therapeutics, 48(1), 131. https://doi.org/10.1016/j.clinthera.2025.11.011

Chicago Style (17th ed.) Citation

J, Shin, et al. "Corrigendum to "Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension" (Clin Ther. 2025 Oct 28. [Epub Ahead of Print])." Clinical Therapeutics 48, no. 1 (2026): 131. https://doi.org/10.1016/j.clinthera.2025.11.011.

MLA (9th ed.) Citation

J, Shin, et al. "Corrigendum to "Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension" (Clin Ther. 2025 Oct 28. [Epub Ahead of Print])." Clinical Therapeutics, vol. 48, no. 1, 2026, p. 131, https://doi.org/10.1016/j.clinthera.2025.11.011.